Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Related Citations for PubMed (Select 21266355)


In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection.

Marotta D, Karar J, Jenkins WT, Kumanova M, Jenkins KW, Tobias JW, Baldwin D, Hatzigeorgiou A, Alexiou P, Evans SM, Alarcon R, Maity A, Koch C, Koumenis C.

Cancer Res. 2011 Feb 1;71(3):779-89. doi: 10.1158/0008-5472.CAN-10-3061. Epub 2011 Jan 25.


Hypoxia and VEGF mRNA expression in human tumors.

Ziemer LS, Koch CJ, Maity A, Magarelli DP, Horan AM, Evans SM.

Neoplasia. 2001 Nov-Dec;3(6):500-8.


Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5.

Ziemer LS, Evans SM, Kachur AV, Shuman AL, Cardi CA, Jenkins WT, Karp JS, Alavi A, Dolbier WR Jr, Koch CJ.

Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):259-66. Epub 2002 Nov 23.


Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.

Evans SM, Jenkins WT, Shapiro M, Koch CJ.

Adv Exp Med Biol. 1997;411:215-25.


2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.

Evans SM, Jenkins WT, Joiner B, Lord EM, Koch CJ.

Cancer Res. 1996 Jan 15;56(2):405-11.


Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.

Damert A, Machein M, Breier G, Fujita MQ, Hanahan D, Risau W, Plate KH.

Cancer Res. 1997 Sep 1;57(17):3860-4.


Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis.

Ragel BT, Couldwell WT, Gillespie DL, Jensen RL.

Neurosurg Rev. 2007 Jul;30(3):181-7; discussion 187. Epub 2007 May 8.


HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.

Dragowska WH, Warburton C, Yapp DT, Minchinton AI, Hu Y, Waterhouse DN, Gelmon K, Skov K, Woo J, Masin D, Huxham LA, Kyle AH, Bally MB.

Mol Cancer Res. 2004 Nov;2(11):606-19.


Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemia.

Bergeron M, Evans SM, Sharp FR, Koch CJ, Lord EM, Ferriero DM.

Neuroscience. 1999;89(4):1357-66.


18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model.

Chitneni SK, Bida GT, Yuan H, Palmer GM, Hay MP, Melcher T, Wilson WR, Zalutsky MR, Dewhirst MW.

J Nucl Med. 2013 Aug;54(8):1339-46. doi: 10.2967/jnumed.112.116293. Epub 2013 Jun 5.


Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.

Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, Ringnér M, Mörgelin M, Bourseau-Guilmain E, Bengzon J, Belting M.

Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7. doi: 10.1073/pnas.1220998110. Epub 2013 Apr 15.


Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts.

Vukovic V, Haugland HK, Nicklee T, Morrison AJ, Hedley DW.

Cancer Res. 2001 Oct 15;61(20):7394-8.


Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.

Méndez O, Zavadil J, Esencay M, Lukyanov Y, Santovasi D, Wang SC, Newcomb EW, Zagzag D.

Mol Cancer. 2010 Jun 1;9:133. doi: 10.1186/1476-4598-9-133.


Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2.

Anelli V, Gault CR, Cheng AB, Obeid LM.

J Biol Chem. 2008 Feb 8;283(6):3365-75. Epub 2007 Nov 30.


Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.

Fujiwara S, Nakagawa K, Harada H, Nagato S, Furukawa K, Teraoka M, Seno T, Oka K, Iwata S, Ohnishi T.

Int J Oncol. 2007 Apr;30(4):793-802.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk